|Biography and Research Interests
|I do research and knowledge translation on health care policy, with an emphasis on pharmaceutical policies that aim to balance three sometimes-competing goals: providing equitable access to necessary care, managing health expenditures, and promoting valued innovation.
I earned degrees in economics from the University of Western Ontario, Queen’s University, and the University of British Columbia. I received post-doctoral training in health care policy at McMaster University and UBC.
Specialties: pharmaceutical policy, health care financing and expenditures, health policy analysis, health services research, equity analysis.
|SPPH 542: Canadian Health Policy
SPHA 510: Canadian Health Policy and the Health Care System
Student Directed Seminar (undergraduate): Health Care System in Canada and the Challenges Ahead
|Bryn Lander, PhD Student, Interdisciplinary Studies
|Understanding the role of the medico-scientific community in translational biomedical research
|I have published over 150 articles, book chapters, and reports for governments. I also write regular editorials for major newspapers and blog posts for websites such as HealthDebate.ca and the Conference Board of Canada.
Publications from the past *2 years*
Morgan, S., J. Daw and M. Law. (2013) “Rethinking Pharmacare in Canada” C.D. Howe Institute: Toronto.
Morgan, S., P. Thomson, J. Daw, and M. Friesen (2013) “Use of product listing agreements by provincial drug benefit plans” Healthcare Policy [in print]
Kawasumi, Y., S. Morgan S., H. Hanley, C. Cunningham, L. So, M. Law, and B. Carleton. (2013) “Ethnic Variation in the Quality of Asthma Management in British Columbia” Journal of Population Therapeutics and Clinical Pharmacology [in print]
Morgan, S., J. Daw, and P. Thomson (2013) “International Best Practices For Negotiating ‘Reimbursement Contracts’ With Price Rebates From Pharmaceutical Companies” Health Affairs 32(4): 771-777.
Morgan, S., P. Thomson, J. Daw, and M. Friesen (2013) “Inter-jurisdictional cooperation on pharmaceutical product listing agreements: views from Canadian provinces” BMC HSR 2013 Jan 31;13:34. doi: 10.1186/1472-6963-13-34
Law, M., J. Daw, L Cheng, and S. Morgan. (2013) “Growth in private payments for health care by Canadian households” Health Policy 110(2): Pages 141-146
Daw, J., S. Morgan S., P. Thomson, and M. Law. (2013) “Here today, gone tomorrow: the issue attention cycle and national print media coverage of prescription drug financing in Canada” Health Policy 110(1): 67-75
So, L., Quan, H., and S. Morgan (2012) “Does concordance between survey responses and administrative records differ by ethnicity for prescription medication?” Journal of Population Therapeutics and Clinical Pharmacology 19(2):e248-58.
Morgan, S. and J. Daw (2012) “Pharmacare in Canada: looking back, looking forward” Healthcare Policy 8(1): 14-23
Morgan, SG, CM Cunningham, and MR Law. (2012) “Innovation or imitation crisis?” BMJ 345:e5880
Puyat, J., M. Law, S. Wong, J. Sutherland, and S. Morgan (2012) “Essential and potentially inappropriate antipsychotic use across income groups: an analysis of linked administrative data?” Canadian Journal of Psychiatry 57(8):488–495
Law, M., L. Cheng, D. Heard, I. Dhalla, and S. Morgan. (2012) “Cost-related Nonadherence to Prescription Drugs in Canada” CMAJ 184(3): 297-302.
Daw, J., B. Mintzes, M. Law, G. Hanley, and S. Morgan (2012) “Prescription drug use in pregnancy: a retrospective population-based study in British Columbia, Canada (2001-2006). Clinical Therapeutics 34(1): 239-249
Morgan, S., P. Thomson, J. Daw, M. Friesen, and A. Dijkstra. (2012) “The public provision of pharmaceuticals: a synthesis of policies in ten developed countries.” Vancouver: UBC Centre for Health Services and Policy Research and the Pharmaceutical Policy Research Collaboration.
Morgan, S., J. Daw and M. Law. (2012) “Pharmacare in Canada: the way forward” Report prepared for the C.D. Howe Institute roundtable on health care policy. Toronto.
Morgan, S., P. Thomson and M. Friesen. (2012) “CAHSPR Planning Update: A summary of the 2011/12 consultations on CAHSPR’s vision, mission, and plans” Report prepared for the Canadian Association for Health Services and Policy Research. Ottawa.
Morgan, S., C. Cunningham and M. Law. (2011) “Changes, Challenges, and Innovations in Pharmaceutical Expenditure Management” Report prepared for the Commonwealth Fund 2011 International Symposium on Health Care Policy. Washington DC.
Law, M., Y. Kawasumi, and S. Morgan. (2011) “Despite Law, Fewer Than One In Five Completed Studies Of Drugs And Biologics Are Reported On Time On Clinicaltrials.gov” Health Affairs 30 (12) 2338-2345
Daw, J., and S. Morgan (2012) “Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes from 2000 to 2010” Health Policy 104(1): 19-26
Greyson, D., C. Cunningham, and S. Morgan (2011) “Information seeking experiences of Canadian pharmaceutical policy makers” Health Information and Libraries Journal doi: 10.1111/j.1471-1842.2011.00969.x
Puyat, J., G. Hanley, C. Cunningham, M. Law, S. Wong, J. Sutherland, and S. Morgan (2011) “Ethnic disparities in antipsychotic drug use in British Columbia: a cross-sectional retrospective study of linked survey and administrative data” Psychiatric Services 62(9): 1026-1031
Morgan, S. and C. Cunningham (2011) “Population aging and the determinants of health care expenditures: the case of hospital, medical, and pharmaceutical care in British Columbia, 1996 to 2006” Healthcare Policy 7(1): 68-79 **
Law, M., A. Ystma, and S. Morgan. (2011) “The Short-term Impact of Ontario’s Generic Pricing Reforms” PLoS ONE 6(7): e23030
Daw, J., G. Hanley, D. Greyson, and S. Morgan (2011) “Prescription drug use during pregnancy in developed countries: a systematic review” Pharmacoepidemiology and Drug Safety 20(9): 895-902. DOI: 10.1002/pds.2184
Law, M., B. Mintzes, and S. Morgan. (2011) “Sources and popularity of online drug information: an analysis of top search engine results and web page views” Annals of Pharmacotherapy 45(3):350-6
Hanley G., S. Morgan, and R. Reid. (2011) “Income-related inequity in initiating on evidence-based therapies among patients with acute myocardial infarction” Journal of General Internal Medicine DOI: 10.1007/s11606-011-1799-1
Law, M. and S. Morgan. (2011) “Purchasing prescription drugs in Canada: hang together or hang separately” Healthcare Policy 6(4): 22-26
Morgan, S., G. Hanley, C. Cunningham, and H. Quan. (2011) “Ethnic differences in the use of prescription drugs in British Columbia: a cross-sectional analysis of linked survey and administrative data” Open Medicine 5(2) http://www.openmedicine.ca/article/view/428/404
Cunningham, C., G. Hanley, and S. Morgan (2011) “Income inequities in End-of-life Health Care Spending in British Columbia, Canada: a pooled cross-sectional analysis” International Journal for Equity in Health 10:12 doi:10.1186/1475-9276-10-12
Hanley G., S. Morgan, M. Barer, and R. Reid. (2011) “The redistributive effect of the move from age-based to income-based prescription drug coverage in British Columbia, Canada” Health Policy doi:10.1016/j.healthpol.2010.12.005
Chafe, R, A. Culyer, M. Dobrow, P. Coyte, C. Sawka, S. O’Reilly, K. Laing, M. Trudeau, S. Smith, J. Hoch, S. Morgan, S. Peacock, R. Abbott, and T. Sullivan. (2011) “Access to Cancer Drugs in Canada: Looking Beyond Coverage Decisions” Healthcare Policy 6(3): 28-36
Law, M., A. Dijkstra, J. Douillard, and S. Morgan. (2011) “Geographic Accessibility of Community Pharmacies in Ontario” Healthcare Policy 6(3)
Morgan, S., P. Grootendorst, J. Lexchin, C. Cunningham, and D. Greyson. (2011) “The cost of drug development: a systematic review of published literature” Health Policy 100(1): 4-17 doi:10.1016/j.healthpol.2010.12.002
I am currently recruiting graduate students interested in the following areas:
(1) Equity in access to necessary medicines
(2) Sex, Gender and Pharmaceutical Policy
(3) Political and economic aspects of pharmaceutical policies in Canada and abroad